Fundraising FoxPharming Group
1 known investors
Find your way into Pharming Group
Sign up to see every warm intro you have to Pharming Group
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Pharming Group team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Pharming is an integrated biotechnology company that develops and delivers targeted therapies for rare and ultra-rare immunological and genetic diseases, including hereditary angioedema (HAE), activated PI3K delta syndrome (APDS), and primary mitochondrial disease (PMD). It spans clinical development, manufacturing, regulatory affairs, and commercialization for the rare disease community.
Investors · 1
Frequently asked questions
- What does Pharming Group do?
- Pharming is an integrated biotechnology company that develops and delivers targeted therapies for rare and ultra-rare immunological and genetic diseases, including hereditary angioedema (HAE), activated PI3K delta syndrome (APDS), and primary mitochondrial disease (PMD). It spans clinical development, manufacturing, regulatory affairs, and commercialization for the rare disease community.
- Who are Pharming Group's investors?
- Pharming Group's investors include Sequoia Capital.